Clinical trial Recruiting at 1 site Observational Ages 18 and up

Monitoring the Saphir Stem in Hip Surgery

Official title: Post-marketing Surveillance Study of the Saphir Stem in Primary Hip Surgery

Run by Gruppo Bioimpianti S.r.l. · NCT05649007 · Data updated 2026-11-12

This study looks at how well the Saphir stem used in hip replacement surgery works for patients over time, focusing on their recovery and quality of life.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment630 (estimated)
SponsorGruppo Bioimpianti S.r.l.
Industry-sponsored
Locations1 site (Toulouse)
StatusRecruiting
StartedSeptember 30, 2022
Main results expectedSeptember 30, 2035
Study endsSeptember 30, 2036
Registry record updatedDecember 13, 2022
Trial IDNCT05649007 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults over 18 years old who are scheduled for primary total hip replacement due to osteoarthritis or femoral neck fractures.

Probably not a fit

Patients under 18, those who are pregnant, or individuals with prior hip surgery on the same side will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates the long-term survival rate of the Saphir stem used in primary hip arthroplasty. It involves post-marketing surveillance to assess patient outcomes, including functional improvement, quality of life, and safety related to the prosthesis. Patients undergoing hip replacement surgery with the Saphir stem and associated systems will be monitored for adverse events and overall effectiveness over time.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into the durability and effectiveness of the Saphir stem, potentially improving patient outcomes in hip arthroplasty.

How similar studies have gone: While this study focuses on post-marketing surveillance, similar studies have shown success in evaluating the long-term outcomes of hip prostheses.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* patients\>18 years
* Candidate for primary total hip replacement with femoral stem and acetabular cup
* if ostheoarthritis patients aged 18 to 85 years
* if femoral neck fracture patients aged 18 to 90 years
* patients with social security scheme
* patients understands the condition of the study and is willing to partecipate for the duration of the clinical investigation
* patients who gavee consent to partecipare in the clinical investigation

Exclusion Criteria:

* \<18 years
* if female, pregnant
* patient who has already had primary hip surgery on the same side
* local or disseminated neoplastic disease
* inability to understand the study and agree to partecipate
* patients cancelling partecipation before surgery
* patients under guardianship or curatorship
* patients without a social security scheme
* patients refusing to partecipate

Where it's running

  • Hopital Ducuing
    Toulouse, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.